As the leading supplier of Recombinant Insulin for innovative biologics, Novo Nordisk Pharmatech helps you keep development on track, production flowing, and products timely supplied to hospitals and patients.
Recombinant Insulin is used for the manufacturing of monoclonal antibodies, virus vaccines, gene therapy products, and other biological drug products approved by regulatory bodies worldwide, including FDA and EMA.
Find below our collection of educational material about Insulin Human AF and explore how it has been used to improve cell culture and boost protein production.
In case of any further questions, please contact us here.
We provide excellence at every step of the supply chain, beginning with the quality of our insulin, directly sourced from Novo Nordisk A/S, the largest producer of insulin in the world. With 100 years of experience with Insulin, Novo Nordisk ensures the most stable and well-established manufacturing processes and specialist know-how on the market.
Recombinant Insulin is a recombinant protein, consisting of human insulin crystals, a biosynthetic product expressed by recombinant microbial expression in yeast.Learn more